SyndromeX
Drugs for Metabolic Syndrome
StartupSyndromeX is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2008. Drugs for Metabolic Syndrome . SyndromeX was founded by Jacob Bar-Tana, MD, Ph.D.. The company has 1-10 employees.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Funding
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQJerusalem
- DistrictJerusalem District
- Last RoundUndisclosed
Jacob Bar-Tana, MD, Ph.D.Founder
1 article covered by sources including patents.justia.com.
What does SyndromeX do?
SyndromeX is a pharmaceutical company that develops drugs for metabolic syndrome and related diseases such as dyslipidemia, type-2 diabetes, obesity, hypertension, and atherosclerotic cardiovascular disease. In an effort to keep metabolic syndrome patients from having to take five to eight different drugs, SyndromeX aims to develop an all-in-one therapy for the disorder and its component diseases.
Who founded SyndromeX?
SyndromeX was founded in 2008 by Jacob Bar-Tana, MD, Ph.D. (Founder).
What sector is SyndromeX in?
SyndromeX operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Drug Delivery. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is SyndromeX located?
SyndromeX is based in Ein Karem, Jerusalem, Israel, Jerusalem District.